Hengrui Pharmaceuticals holds a listing hearing on Hong Kong Exchanges and Clearing Limited.

Lifemore Securities showed that Jiangsu Hengrui Medicine Co., Ltd. has completed the listing hearing on the Hong Kong Stock Exchange, with Morgan Stanley, Citigroup, and Huatai International as joint sponsors.